LEO Pharma A/S
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
- Digital Health
- Disease Management
Other Names/Subsidiaries
- Laboratoires Leo
- LEO Pharma
- Peplin
Latest on LEO Pharma A/S
Leo Pharma is ready to hit the ground running with the US launch of Anzupgo after getting the green light across the Atlantic for the treatment of chronic hand eczema (CHE). Anzupgo (delgocitinib) was
The US Food and Drug Administration’s approval decisions for novel agents will come from different divisions in the second half of 2025, compared to the first half, the Pink Sheet ’s US FDA Performan
Leo Pharma’s mission to be the partner of choice in the field of medical dermatology has been bolstered by an eye-catching deal to commercialize and further develop Boehringer Ingelheim’s flagship ski
With 22 novel agents approved in the first six months of 2025, the US FDA is already behind its average approval count for the first half of the year, and the user fee calendar for the second half doe